Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001144204-18-005222
Filing Date
2018-02-01
Accepted
2018-02-01 17:30:59
Documents
8

Document Format Files

Seq Description Document Type Size
1 F-1/A tv484585_f1a.htm F-1/A 2167341
2 EXHIBIT 10.12 tv484585_ex10-12.htm EX-10.12 73789
3 EXHIBIT 23.1 tv484585_ex23-1.htm EX-23.1 5571
4 GRAPHIC pg97img1_20f.jpg GRAPHIC 4158
5 GRAPHIC tv484585_img1.jpg GRAPHIC 25979
6 GRAPHIC tv484585_img2.jpg GRAPHIC 74959
7 GRAPHIC tv484585_img3.jpg GRAPHIC 25940
8 GRAPHIC logo.jpg GRAPHIC 2909
  Complete submission text file 0001144204-18-005222.txt   2432846
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: F-1/A | Act: 33 | File No.: 333-208817 | Film No.: 18567863
SIC: 2834 Pharmaceutical Preparations